ESMO26: US and FDA movements to improve oncology trials a positive signal
Since the Trump Administration took office in the White House, there has been an uptick in the number of guidance…
Analysis
Darzalex Faspro for the Treatment of Light Chain (AL) Amyloidosis, US
Podcast: Do PI signatures really signal meaningful oversight?
Real-time clinical trials: what it means for procurement strategy
ISEMBYLD for the Treatment of Spinal Muscular Atrophy, US
DANYELZA (naxitamab-gqgk) for the Treatment of Neuroblastoma, US
Trials to watch: First cancer vaccine success could trigger a domino effect
Women’s health landscape shifting, but systemic hurdles remain
